// App-Quantinova.ai

96 : AB1, a novel protein targeting TP53 mutated GI tumors.

Researchers

Presenter

  • Agamemnon A. Epenetos

Principal Investigators

  • Karima Karagussova

  • Mahendra Deonarain

Medical Centers

  • Guy's Hospital, London, United Kingdom

  • NCRI, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Tumor protein p53

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved